a single cell population, the hemangioblasts, gives rise to ECs in arterial, capillary, venous, and lymphatic vessels, which are known to differ in their pattern of gene Summary expression. For example, lymphatic ECs have high expression of VEGFR-3/FLT-4, whereas the expression of Venous malformations (VMs), the most common errors this cytokine receptor in veins and arteries is almost of vascular morphogenesis in humans, are composed undetectable (Kaipainen et al., 1995) . Furthermore, exof dilated, serpiginous channels. The walls of the chantracellular matrix can modulate the effects of ECs on nels have a variable thickness of smooth muscle; some SMC migration and adhesiveness (Powell et al., 1996a) , mural regions lack smooth muscle altogether. A misand EC proliferation can be inhibited by contact with sense mutation resulting in an arginine-to-tryptophan SMCs and pericytes (Orlidge and D'Amore, 1987) . As a substitution at position 849 in the kinase domain of result, there are structural differences in the walls of the receptor tyrosine kinase TIE2 segregates with mature vessels in different segments of the vascular dominantly inherited VM in two unrelated families. Ustree, and cell signaling pathways are likely to differ in ing proteins expressed in insect cells, we demonstrate morphologically or functionally distinctive segments of that the mutation results in increased activity of TIE2.
the vascular system. We conclude that an activating mutation in TIE2
Genetic vascular disorders in humans provide moleccauses inherited VMs in the two families and that the ular insights into these pathways. For example, heredi-TIE2 signaling pathway is critical for endothelial celltary hemorrhagic telangiectasia (Rendu-Osler-Weber smooth muscle cell communication in venous morsyndrome), in which there is a gradual alteration in the phogenesis.
capillary bed between venules and arterioles, has been shown to be caused by mutations in two TGF␤ binding proteins, endoglin and activin receptor-like kinase Introduction (McAllister et al., 1994; Johnson et al., 1996) . As a result of localized capillary dilatation, arterial blood is shunted Vascular morphogenesis begins as vasculogenesis, in directly into postcapillary venules, which in turn become situ differentiation of endothelial cells (ECs) from hemangioblasts, and subsequent formation of endothelial convoluted and "arterialized," manifesting increased three unaffected individuals IV-9, II-21, and IV-16 are nonpenetrant for the disease phenotype. smooth muscle within their walls. These findings suggest that TGF␤ signaling pathways are crucial for the development and maintenance of normal capillary beds.
The Receptor Tyrosine Kinase TIE2 Gene In ataxia-telangiectasia, intracellular signaling errors Is Localized within the VMCM1 Locus due to mutations in a protein kinase/phosphatidylinosiFor positional cloning and candidate gene identification, tol kinase homolog cause abnormalities in cell cycle we obtained two human melanoma cell lines (MN455 control, resulting in telangiectases (Savitsky et al., 1995) . and W) containing previously defined homozygous deleVenous malformation (VM) is the most common develtions of 9p and a YAC contig covering the 8 cM region opmental vascular anomaly. VMs are usually sporadic from the IFN gene cluster to the marker D9S161 (generand solitary, but they can also be familial and typically ously provided by Dr. Frank Haluska). The EC-specific are multifocal. They are usually located in skin and mureceptor tyrosine kinase TIE2 gene had been mapped cosal membranes, but any organ can be affected (Mullipreviously to 9p21 by in situ hybridization (Dumont et ken and Young, 1988) . VMs are seen either at birth or al., 1994); we wanted to test whether it was localized to later in life. The molecular basis for VMs is unknown. the linked interval. Using DNA from the cell lines and To gain insight into the cause of VM, we have studied YAC clones as template for polymerase chain reaction two unrelated families with dominantly inherited muco-(PCR), we found that DNA from cell line MN455 was cutaneous VMs. Using random linkage mapping, we positive for TIE2, whereas DNA from cell line W was found that the locus for a gene causing the malformanegative. Since cell line MN455 has a deletion of the tions is on the short arm of chromosome 9 (Boon et al.,
IFN gene cluster and cell line W is deleted between 1994; Gallione et al., 1995) . Here we report that the IFNA and D9S3, the TIE2 gene had to lie between these receptor tyrosine kinase TIE2 gene is localized within markers. Of the 24 tested YAC clones, IG4D7, 7I1C4, this locus, and that a C-to-T nucleotide transition, lead874c7, 822f8, 899b9, and 882f4 were positive with TIE2-ing to an arginine-to-tryptophan substitution at position specific PCR. Since these clones were also positive 849 (R849W) in the kinase domain of the receptor, cofor D9S169 (located between IFNA and D9S3), and the segregates with the phenotype in the two families. Fursmallest of the clones, 874c7, was 560 kb in size, the thermore, by using a baculovirus expression system, we TIE2 gene had to lie in the vicinity of this marker within demonstrate that the R849W change causes increased the linked interval. activity of the TIE2 kinase. Using immunohistochemistry of lesions, we also show that affected vessels contain A Single Nucleotide Change in TIE2 a disproportionately large number of ECs versus SMCs.
Segregates with the Phenotype Therefore, we conclude that the developmental venous in Two Unrelated VM families anomalies in the two families are caused by local uncouTo analyze TIE2 as a candidate gene in the two VM pling between the normal recruitment of SMCs and the families, we used Epstein-Barr virus to transform lymproliferation of ECs. This uncoupling is due to an activatphocytes taken from two patients in family SA (individuing mutation in TIE2 and indicates that the TIE2 signaling als III-7 and II-13, Figure 1 ), one patient in family AF pathway is crucial for the normal development of veins.
(individual IV-13, Figure 1B) , and control individuals. We extracted total RNA from the cultured cells and used it as template for reverse transcription PCR. PCR primers Results for nine overlapping fragments were synthesized to cover the whole 3375 bp coding sequence of the TIE2 Inherited VM in Two Families Is Linked to an Interval on Chromosome 9p21
gene. Cycle sequencing of these products identified: two nucleotide polymorphisms that do not change the We have described linkage of inherited VM in two families to markers on the short arm of chromosome 9 codon for an amino acid (G1962A and G2322A); a singleamino acid-deletion polymorphism (valine 788; bovine (VMCM1; OMIM number 600195) (Boon et al., 1994; Gallione et al., 1995) . The linked interval was defined by and rat sequences have the valine residue and the murine does not); and a T2084C change resulting in an recombinant markers D9S157 and D9S161. We evaluated 35 additional members of the family SA (Figure isoleucine-to-threonine substitution that was confirmed to be homozygous in our samples and in a partial human 1A) and narrowed the interval to 8 centimorgans (cM) between the IFN gene cluster and marker D9S161 (data TIE2 clone (kindly provided by Dr. Kari Alitalo). In the murine, bovine, and rat sequences, a threonine residue not shown). Three members of family SA and one member of family AF were recombinant for the entire interval.
is found at this position, suggesting that threonine 2084 is an error in the previously published human sequence. Individual II-15 in family SA had a single cervical lesion but had not inherited the haplotype linked to the disease, We also identified a C-to-T transition at position 2545 that changes an arginine to a tryptophan residue (Figure whereas unaffected individuals IV-9, a 14-year-old boy, and II-21, an 81-year-old man, had inherited the haplo-2A). To confirm that the C2545T transition was present in genomic DNA and that this nucleotide substitution type. The cervical lesion in individual II-15 appeared in early adulthood, whereas lesions in her relatives were cosegregated with the phenotype in family SA, we tested all 61 family members with allele-specific PCR (Figure multiple and became apparent clinically at an earlier age. It is therefore probable that she represents a spo-2B). All affected individuals carried this change, except II-15, who was recombinant for the whole region. In radic case. Individual IV-16, an unaffected 32-year-old woman in family AF, also had inherited the haplotype addition, the unaffected individuals IV-9 and II-21 carried this nucleotide substitution. We also tested 138 control linked to the disease ( Figure 1B) . We assume that the individuals from Canada, Finland, and the United States, the human, bovine, murine, and rat sequences (GenBank accession numbers L06139, X71424, X71426, and but none of them had the C-to-T transition.
To test whether the same nucleotide change, C2545T, 386048). In the homologous TIE1 receptor, the arginine is replaced by a lysine in the human, bovine, and murine existed in family AF, genomic DNA from all family members was amplified and evaluated with a MaeIII restricsequences (GenBank accession numbers X60957, X71423, and X71425). This suggests that a basic residue tion fragment-length analysis, since the mutation destroys a MaeIII site. All affected individuals as well as in this position is important for the kinase structure or function. the unaffected individual IV-16 were heterozygous for the substitution. To rule out that this nucleotide change
To study the biochemical effect of this change on kinase function, we cloned the full-length wild-type and was a founder mutation and that the two families may be related, we genotyped affected individuals from both mutant TIE2 cDNA into a baculovirus expression vector. Recombinant viruses were obtained and several clones families for the sizes of associated STRP alleles. The linked haplotypes differed from each other both for were purified. Using rabbit anti-TIE2 antibody (Santa Cruz), TIE2 protein was immunoprecipitated from inflanking markers as well as for an intragenic nucleotide polymorphism ( Figure 3) . sect cell extracts. Western blotting showed a specific 140 kDa band, the expected size for TIE2 ( Figure 4A ); immunoblotting with anti-phosphotyrosine antibodies The R849W Mutation in TIE2 Causes Kinase Activation showed that both wild-type and mutant receptors in the extracts were autophosphorylated, but the mutated The mutated arginine 849, located six amino acid residues upstream of the invariant lysine in the first intracelreceptor protein was phosphorylated to a higher extent than the wild-type protein (data not shown). In addition, lular kinase domain of TIE2 (see below), is conserved in when the immunoprecipitates were incubated with veins and arteries with normal structure were seen adjacent to abnormal channels within the tissue specimens [␥-32 P]ATP before gel electrophoresis, autoradiography suggested that the mutant receptor had a 6-to 10-( Figure 5C ). Immunostaining with antibodies against CD31 (data fold higher autophosphorylation activity in vitro than the wild-type receptor ( Figure 4A) . not shown) and von Willebrand factor (vWF) showed specific staining of the luminal cells lining blood vessel The wild-type and mutant receptors were also incubated with a synthetic tyrosine-oriented peptide library (Songwalls ( Figure 5A ). Positive vWF staining was also seen in intraluminal platelets. With high magnification, flattened yang et al., 1995) to assay for differences in the ability to phosphorylate peptide substrates. The phosphorylated ECs were seen to line the abnormal channels. Endothelial nuclei were located far apart from one another, but peptides were separated from nonphosphorylated peptides and sequenced. We detected no differences in there was no endothelial discontinuity. Antibodies against SMC ␣-actin demonstrated spespecificity between the wild-type and mutant receptors. However, the mutant protein was much more active at cific but patchy and irregular staining of the abnormal channels as compared with the uniform layer of stained phosphorylating peptides in the library ( Figure 4B ). cells around normal veins ( Figures 5B and 5C ). In the abnormal channels the staining intensity varied with the VMs Contain a Disproportionately High size of the vessels. Small channels typically showed Ratio of ECs to SMCs prominent staining, as compared to larger channels, VMs excised from members of family SA showed dilated some of which were devoid of ␣-actin staining. Scatvascular channels of variable diameter (Figures 5A and tered SMCs were discernible at high magnification. Dis-5B). Specimen II-7 exhibited only few ectatic veins, organized smooth muscle was seen in the adjacent veswhereas specimen II-8, taken from a large anomaly afsel wall whenever there was evidence of a mural fecting one third of the tongue (for clinical picture, see thrombus, a pathognomonic finding in VMs. Boon et al., 1994) , and specimen II-5 ( Figure 5 ) were composed of numerous serpiginous channels. Of note, Discussion
VM Is Caused by a Mutation in the TIE2 Receptor Tyrosine Kinase
Based on the localization of the TIE2 gene in the minimal candidate interval of 8 cM, the identification of the same nucleotide transition in affected individuals of two unrelated families, and the increased kinase activity of the mutant receptor in vitro, we conclude that VMs are caused by a mutation in the TIE2 receptor. This is supported by the EC-specific expression pattern of TIE2 (Dumont et al., 1995) . We have shown that a nucleotide transition, C2545T, results in an R849W substitution. This is not a common polymorphism because the C-to-T transition was not detected in 138 control individuals. The same mutation was also identified in two disparate VM families. Family SA is of Italian origin and family AF of German origin, and thus it is unlikely that the mutated allele could be derived from a common ancestor. Indeed, haplotype analyses of flanking markers and an intragenic polymorphism demonstrated that the mutations occurred in two Figure 1A) showing amplification of the mutant allele (193 bp) with an internal control (800 bp). VI, size marker; plus, carrier; minus, normal; question mark, sample did not work. The C2545T mutation is flanked by different alleles of the intragenic G2322A polymorphism and either D9S169 or GATA165A11 in the two families, since the orientation of the TIE2 gene on the chromosome is unknown. TIE2 and D9S169 are maximally 560 kb apart, the size of the smallest YAC clone, y874c7, containing both markers. different TIE2 alleles, suggesting that the R849W change tion of a single amino acid residue (G380R) in the trans-(B) Anti-TIE2 immunoprecipitates described in (A) were used to membrane domain of fibroblast growth factor receptor phosphorylate an oriented random peptide library. Shown is the 3 (FGFR3) (Bellus et al., 1995) .
observed peptide phosphorylation for each of the precipitates, normalized to the activity associated with the wild-type TIE2 receptor.
Of note, a single-amino acid-length polymorphism Since the expression levels of R2 are 2-to 3-fold higher than those was also identified in the kinase domain of the TIE2 of W2, the autophosphorylation and substrate phosphorylation acreceptor. The polymorphic valine residue (788) is not tivities of mutant TIE2 are 6-to 10-fold those of wild-type receptor. present in the murine TIE2 sequence but is present in Error bars, standard error of three independent experiments. the bovine and rat TIE2. The length variations between the murine, human, and bovine sequences (1122, 1124, overexpressed, even without ligand. It has been sugand 1125 amino acid residues, respectively) suggest gested that receptors that need ligand binding for dimerthat small differences in the number of amino acids can ization and subsequent autophosphorylation have a occur without interruption of the function of the protein.
weaker intrinsic inhibitory mechanism of autophosphorWe confirmed that it is a polymorphism by identifying ylation (Mohammadi et al., 1996) . This may be true for homozygous and heterozygous individuals for the ab-TIE2, which is believed to form dimers after ligand sence of valine 788.
binding. How does the R849W change increase kinase activity? The substituted arginine 849 is located six residues The R849W Mutation Causes Increased Phosphorylation Activity of TIE2 upstream of the invariant lysine in the kinase domain and is conserved among human, bovine, murine, and Overexpression studies of full-length wild-type and mutant receptors in insect cells showed an increase in rat TIE2 sequences; in the homologous receptor, TIE1, another basic amino acid residue, lysine, is found at autophosphorylation activity for the mutant form. Not only was the mutant protein more phosphorylated than the same position in the human, bovine, and murine sequences. This suggests that a basic residue is importhe wild-type protein when assayed directly by immunoblotting of insect cell extracts, it also showed a 6-to tant at this position. In the crystal structure of the FGFR1 kinase domain, an arginine residue, 38 amino acid resi-10-fold higher autophosphorylation activity in vitro when incubated with [␥-32 P]ATP. Like many other growth facdues upstream of the invariant lysine, is found hydrogenbonded to the carbonyl group of a downstream proline tor receptors, TIE2 is easily autophosphorylated when kinase domains, arginine 849 is located on an outward curving loop (Figure 6 ), a loop that could be involved in dimerization. residue, suggesting an important role in the stabilization of the amino-terminal lobe of the kinase domain (Mo-A graded activation of receptor function is seen with certain amino acid substitutions in FGFR3 that cause hammadi et al., 1996) . If arginine 849 in TIE2 is involved similarly in stabilizing the kinase domain, it could be that osteochondrodysplasias of differing severity (Naski et al., 1996; Webster et al., 1996). One of these mutations, its substitution by tryptophan alters the conformation G380R, the cause of achondroplasia, is located in the transmembrane domain and has a weak activating effect on the receptor, resulting in 15%-20% ligand-independent mitogenic activity. Another mutation, K650E, located in the activation loop of the FGFR3 kinase domain (Figure 6 ), results in a 100-fold increase in autophosphorylation (Webster et al., 1996) . Of note, when a number of other residues in the region of lysine 650 (the ␤10-␤11 region) were mutated to glutamine, no activation of the kinase was observed (Webster et al., 1996) . Thus, mutations involving residues only at specific locations in FGFR3 alter kinase activity. The R849W mutation in TIE2 may represent a similar case.
Based on the observations of FGFR3 mutations, it has and activation (Naski et al., 1996) . If a similar ligand-TIE2-ligand loop is coupled to PDGF/TGF␤-mediated chemotaxis, independent dimerization explains how the TIE2 mutaproliferation, and differentiation of SMCs.
tion causes the vascular changes seen in mucocutaneous VM, it might also explain why these malformations may therefore lead to abnormal sprouting, branching, are localized and variable in number, shape, and size. and remodeling. We believe that the dominantly inherIf homodimers of mutant subunits are more active than ited R849W substitution in the two VM families reprehomo-and heterodimers containing wild-type protein, sents such a gain of function mutation. The lesions confocal stochastic variations in the expression of the wildtain large venous channels with a disproportionately low type and mutant alleles could change receptor activity number of SMCs. Whether the formation of the abnormal and thus locally modulate TIE2 signaling in ECs. Loss vessels involves abnormal local proliferation of ECs is of the wild-type allele (due to a somatic mutation), similar not known. VM endothelium in a specimen from an to that recently reported for defects in Gorlin's syndrome 8-year-old girl stained negatively for two proliferating (Levanat et al., 1996) , may also result in clonal expansion cell markers (Ki-67 and E-selectin) (Kraling et al., 1996) , of ECs expressing only the mutant receptor. Such variapossibly because the VMs examined were established, tion in expression could also explain why three family not growing, lesions. members were carriers of the mutation yet clinically It is likely that the activity of the TIE2 signaling pathway unaffected, reducing the observed penetrance to 94%.
is at least partially regulated by surrounding mesenchyme since ligands that activate TIE2 are expressed by mesenchymal cells (Davis et al., 1996 [ 
this issue of The Disproportionate Number of ECs and SMCs in VMs Is Caused by Activation of TIE2
Cell]). Thus, TIE2 signaling in ECs and expression of the ligands in mesenchymal cells are linked. We hypothesize Immunohistochemical analysis showed that the distended vascular channels contain a continuous EC layer that ligand expression is controlled by a feedback loop, with an EC signal negatively affecting the expression of surrounded by a highly variable thickness of smooth muscle. Some areas of the channel walls contain a relaligands by SMCs (Figure 7) . Furthermore, we suggest that the TIE2 loop is coupled to EC-controlled SMC tively normal number of SMCs, whereas other regions are totally devoid of muscle ( Figure 5 ). The structure of chemotaxis, proliferation, and differentiation during normal morphogenesis of veins and that it is uncoupled the SMC layer is also disorganized. The diameter of the abnormal vessels can be ten times that of normal in VMs, since the malformations appear to contain a disproportionate number of ECs relative to investing channels, suggesting that the dysmorphogenesis involves abnormal venous growth or remodeling caused smooth muscle. Numerous in vitro and in vivo studies show that PDGF by a local uncoupling between proliferation and differentiation of ECs and SMCs.
and TGF␤ play major roles in controlling SMC chemotaxis, proliferation, and differentiation. Exogenous What is already known about the TIE2 signaling pathway supports the hypothesis that it is essential for early PDGF can act as a mitogen and chemoattractant for SMCs and pericytes (Grotendorst et al., 1981 ; Grotenvascular development. TIE2 knockout mice and mice with a dominant-negative mutation in TIE2 have 30% dorst et al., 1982; Westermark et al., 1990; D'Amore and Smith, 1993) . SMCs, reciprocally, can regulate EC and 75% fewer ECs in embryos at days 8.5 and 9.0, respectively, when compared to wild-type embryos (Duexpression of PDGF-B, suggesting that there is a feedback loop between the cells in vivo (Bonin and Damon, mont et al., 1994) . The knockout embryos as well as the transgenic embryos die at about embryonic day 9.5-10.5 1994). Furthermore, the expression patterns of PDGF-B and its receptor PDGF␤R in angiogenic ECs and surwith malformation of the vascular network Sato et al., 1995) , and it has been suggested rounding mesenchymal cells as well as data from mice with inactivated PDGF-B and PDGF␤R alleles suggest that TIE2 signaling is important for sprouting and branching or remodeling of the primary capillary plexus that PDGF plays an important role in vascular morphogenesis (Holmgren et al., 1991; Shinbrot et al., 1994; (Sato et al., 1995) . A gain of function mutation in TIE2 Analysis of the TIE2 Gene Soriano, 1994; Leveen et al., 1994) . TGF␤1 has been Total RNA was extracted from Epstein-Barr virus-transformed shown to be an inhibitor of proliferation of SMCs, though lymphoblasts or peripheral blood leukocytes according to the acidnot of pericytes, and a chemoattractant for SMCs (Merguanidinium-thiocyanate extraction protocol (Chomczynski and win et al., 1991; D'Amore and Smith, 1993) . Also, TGF␤ Sacchi, 1987) . Five micrograms of total RNA were used as template is activated in EC--SMC cocultures (Antonelli-Orlidge for cDNA synthesis with oligo(dT) primer using the Superscript Preamplification System (GIBCO-BRL).
et al., 1989) and TGF␤ 1 is believed to be a regulator of Nested PCR reactions were performed in a total volume of 50 SMC differentiation (Desmouliere et al., 1993) . Based on l under the conditions described above. First-round PCRs were these data, we propose that the TIE2 signaling pathway performed for 40 cycles and second-round PCRs for 35 cycles. The is coupled to PDGF/TGF␤-based recruitment of SMCs cycles consisted of 94ЊC for 1 min, 56ЊC or 60ЊC for 1 min (60ЊC for during vascular morphogenesis (Figure 7 ). Whether this 1 min for all second rounds), and 72ЊC for 2 min (1 min for all second coupling occurs at the level of endothelial or mesenchyrounds), followed by a final extension step at 72ЊC for 10 min.
Primers for the first-round PCR reactions were designed so that mal cells is not clear. If the coupling mechanism is localthe 3375 bp coding sequence was amplified in five overlapping ized in ECs, linking PDGF expression to signaling fragments. Two nested primer pairs were used for all but the most through TIE2, it would be predicted to be a negative (nt: Ϫ88 to Ϫ69); TIE2-28 (antisense) 5Ј-GGGCACTGAATGGATGA The Puregene kit was used for DNA extraction following the protocol AGG (nt: 498-479); TIE2-29 (sense) 5Ј-TTCAGTATCAGCTCAAGGGC supplied by the manufacturer (GENTRA Systems). Genotyping of (nt: 2084-2103); TIE2-30 (antisense) 5Ј-GTGTGCCTCCTAAGCTA individuals for markers in the 9p region was performed as described ACA (nt: 3112-3093); and TIE2-31 (antisense) 5Ј-TCATTCTTTTGATG earlier (Boon et al., 1994) . GCAGCATC (nt: 2572-2551). The five primer pairs used for the first-round PCRs were TIE2-11/ TIE2-12, TIE2-13/TIE2-14, TIE2-15/TIE2-17, TIE2-21/TIE2-23, and Localization of the TIE2 Gene TIE2-26/TIE2-27. The nested primer pairs used for the second-round To test whether the TIE2 gene is localized in the linked region, we PCR for each of these first-round PCRs were, respectively, TIE2-3/ obtained DNA from two human melanoma cell lines known to contain TIE2-4, TIE2-1/TIE2-12, TIE2-2/TIE2-30, TIE2-8/TIE2-29, TIE2-16/ homozygous deletions of the 9p region and from 20 YAC clones TIE2-19, TIE2-18/TIE2-20, TIE2-10/TIE2-24, TIE2-22/TIE2-25, and located to the same region (kindly provided by Dr. Frank Haluska, TIE2-7/TIE2-28. Massachusetts Institute of Technology). Cell line W was positive for
To sequence the mutation site from genomic DNA, primers TIE2-IFNA and D9S161 but negative for markers D9S171 and D9S169.
2570 (sense) 5Ј-TCAGGGACTCTGGCCCTAAACAG (nt: 2392-2414) Cell line MN455 was negative for markers telomeric from D9S171, and TIE2-577-ER (antisense) 5Ј-ATATTCTTTCATTCTTTTGATG including IFNA (F. G. Haluska, unpublished data).
GCAGCATC (nt: 2580-2551) were used. Allele-specific PCR was PCR was performed with primers TIE2-3 (sense) 5Ј-GCAGGAATT used to screen family members and controls. Two additional primers GACTGTTCTGC (nt: 3488-3507) and TIE2-4 (antisense) 5Ј-ATGTCTC with similar estimated annealing temperatures were synthesized: CCAAATGTCACCC (nt: 3981-3962), resulting in a 0.9 kb product TIE2-R (antisense) 5Ј-TTGATGGCAGCATCCATCCG (nt: 2564-2545), with genomic DNA as template. PCR reactions were performed in TIE2-W (antisense) 5-ЈTTTGATGGCAGCATCCATCCA (nt: 2565-a total volume of 25 l containing 1 ϫ PCR buffer (Perkin-Elmer), 2545). The analyses were performed using two separate PCRs for 200 M dNTPs, 0.5 M each primer, and 1 U of Taq polymerase.
each template: TIE2-2/TIE2-R or TIE2-2/TIE2-W, both containing an The 35 cycles consisted of 94ЊC for 30 s, 54ЊC for 30 s, and 72ЊC internal control, TIE2-6/TIE2-10 ( Figure 2B ). The reaction conditions for 40 s, followed by a final extension step at 72ЊC for 10 min. To were the same as mentioned above, except that the nucleotide reveal the minimal region where the TIE2 gene can be localized, concentration was 40 M. Each cycle of the PCR consisted of 95ЊC four additional YAC clones were obtained: 874c7, 822f8, 899b9, for 1 min, 68ЊC for 1 min, and 72ЊC for 1 min (30 cycles), with a final and 882f4 (Gé né thon; clones kindly provided by Dr. J. Vance, Duke University).
extension at 72ЊC for 10 min. Cosegregation of the mutation in family AF was studied using MaeIII restriction enzyme digestions of TIE2-antimouse antibody (Promega), were kindly provided by Dr. K. Takahashi (Takahashi et al., 1994) . 2570/TIE2-577-ER amplification products. This 189 bp PCR product contains one MaeIII site (at nt 149) that is abolished by the mutation.
Prior to staining for antibodies, the tissues were incubated with 250 g/ml protease (Sigma Chemical) for 6 mins. Blocking was performed by incubating the slides in 5% skim milk with PBS for 1 Construction of Full-Length Clones of the TIE2 Gene hr. Primary antibodies (diluted 1:100 in PBS) were applied at 4ЊC and Their Expression Using a Baculovirus for 12 hr. After washing with PBS, the secondary antibody (diluted Expression System 1:100 in PBS) was applied for 1 hr at room temperature. Fast-red To clone the 3375 bp coding sequence of the TIE2 gene, cDNA chromogen (Dako) was used for visualization of the immunoreacsynthesized as described above was used as template for nested tions. The reactions were terminated by adding water, and the slides PCR. First-round PCR using primers TIE2-4/TIE2-27 and secondwere mounted using Permount (Fisher Scientific). round PCR with primers TIE2-1/TIE2-7 were performed under conditions as described above, except that Taq extender was used according to the manufacturer's directions (Stratagene). Each cycle Acknowledgments consisted of 94ЊC for 1 min, 60ЊC for 1 min, and 72ЊC for 5 min, with a final extension at 72ЊC for 10 min, for a total of 40 cycles for the The project was supported by the Finnish Cultural Foundation, the first round, and 94ЊC for 1 min, 60ЊC for 1 min, and 72ЊC for 4 min, Academy of Finland (M. V.), Catholic University of Louvain, Belgium, with a final extension at 72ЊC for 10 min, for a total of 35 cycles for
The Foundation for Faces of Children (L. M. B.), American Heart the second round. This full-length amplification product was purified Association-Sanofi-Winthrop award 95006970, the Baxter Foundausing Centricon-100 columns (Amicon) and cloned into the pGemTtion, Sandoz Pharmaceuticals (D. A. M.), the M. B. Gold Family vector (Promega). A clone (#1/#4) containing the full-length TIE2 (M. L. W.), the Lucille P. Markey Charitable Trust (L. C. C.), Organocoding sequence was cycle-sequenced (Perkin-Elmer). Taq-polygenesis Inc., and National Institutes of Health grant HL33014 merase errors were eliminated from the clone by exchanging regions (B. R. O.). M. V. is recipient of a Fogarty International Research between unique restriction enzyme cutting sites in the construct, Fellowship Award; J. T. C. is recipient of a National Science Foundawith corresponding fragments amplified from lymphoblast-derived tion predoctoral fellowship; and D. A. M. is an Established InvestigacDNA with Pfu DNA polymerase (Stratagene). Similarly, the mutation tor of the American Heart Association. We are grateful to all patients site in the original clone was replaced by the corresponding wildand family members who participated in the study. We also thank type sequence. The full-length inserts were cloned into the baculoviDr. K. Alitalo for the TIE2 clone, Dr. F. Haluska for YAC clones and rus expression vector BacPAK8 (Clontech), and the full-length melanoma cell lines, and Dr. J. Vance for YAC clones. Y. Pittel clones, BP-TIE2-R2 and BP-TIE2-W2, were checked by sequencing.
provided expert secretarial assistance. Neither of the clones contained the variant valine 788. No nucleotide changes resulting in amino acid changes were present, other than Received October 28, 1996; revised November 21, 1996. the introduced C-to-T substitution in the BP-TIE2-W2 clone.
Recombinant baculoviruses encoding wild-type and mutated TIE2
